CoreAge Rx is our featured commercial option. Its advertised starting prices are straightforward to find, but the selected billing term, consultation fee and the medical reason for a compounded prescription still need to be understood.
- Care or fulfillment model
- Featured telehealth partner
- Displayed price
- From $99 / month
- Price boundary
- Advertised semaglutide starting price; verify term and total
- Research date
- October 8, 2026
What stands out
- Published starting prices for both medications
- Supplies and shipping advertised as included
- A current help-center catalog explains compounded status
What to weigh
- Compounded drugs are not FDA-approved alternatives with identical evidence
- The selected term and total upfront charge require confirmation
- A declined prescription may still incur a consultation fee
The advertised offer
The CoreAge Rx homepage advertises compounded semaglutide from $99 per month and compounded tirzepatide from $149 per month. It also advertises supplies, shipping and the same price at every dose. These are provider claims recorded on the review date, not the result of a completed purchase or an independent billing audit.[source]
For a cost comparison, ask which plan qualifies for the starting quote and whether it is a monthly charge or the equivalent of a prepaid term. The help-center catalog says multi-month plans are available, so the amount due today may matter as much as the monthly figure.[source]
What you are comparing
The service markets compounded preparations. These are not FDA-approved finished medicines and should not be described as generic Wegovy or generic Zepbound. Sharing an active-ingredient name does not establish interchangeability or transfer branded-drug trial results to a compounded product.[source]
FDA recommends compounded GLP-1 drugs only when a patient’s medical needs cannot be met by an approved drug. A low price alone is not an explanation of that clinical need. Ask the prescriber why the proposed preparation is appropriate and what approved options were considered.[source]
The care pathway
The provider describes an online intake, clinician review and pharmacy fulfillment when treatment is appropriate. Its website also describes access to support. This review did not test response times, independently confirm a pharmacy relationship or experience the treatment process.[source]
Before paying, distinguish questions about an order from medical follow-up. Ask who can answer a side-effect question, how to contact the dispensing pharmacy and what happens if the treatment needs to change. Those details are part of the value of the plan.
The fee detail worth reading
The product catalog says that if treatment is not approved, a refund is the amount paid less a non-refundable consultation fee. That is more specific than assuming “not prescribed” means a complete refund. Obtain the current fee and applicable policy for your selected plan.[source]
Also ask about cancellation timing and prepaid periods. A person who stops future renewals may still have a charge associated with a period already purchased. This review does not infer an unconditional refund or cancellation policy from marketing language.
How it fits the shortlist
CoreAge Rx may be worth investigating if an online compounded-treatment evaluation is the service you want to compare. A person seeking an FDA-approved branded medicine should separately review Ro, Hers or manufacturer-supported fulfillment. Those are not identical products at different prices.
Read the individual semaglutide and tirzepatide reviews, then use the total-cost checklist. Its first position here reflects a commercial placement, not a finding that it is the lowest complete cost or the best medical choice.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
- CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags